Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Molecular Therapy. Nucleic Acids|September 8, 2023
Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humansAntonio Maurizi, Piergiorgio Patrizii, Anna Teti, et al.Bone|May 28, 2026
DPP3 deficiency impacts bone quality and sensitizes to metabolic alterationsEmilia Bevacqua, Valentina Granata, Daniele Panetta, et al.Bone|November 5, 2013
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease modelsImranul Alam, Amie K Gray, Kang Chu, et al.Biochemical Pharmacology|February 5, 2021
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteineChiara Paganini, Chiara Gramegna Tota, Luca Monti, et al.Calcified Tissue International|May 11, 2024
Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S BackgroundSuzanne Saffie-Siebert, Imranul Alam, Flavia Maria Sutera, et al.Ebiomedicine|June 2, 2019
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing miceSilvia Marino, Daniëlle de Ridder, Ryan T Bishop, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 18, 2020
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal DevelopmentElla P Dennis, Sarah M Edwards, Robert M Jackson, et al.Journal of Materials Science. Materials in Medicine|July 3, 2010
Design of novel three-phase PCL/TZ-HA biomaterials for use in bone regeneration applicationsAurelio Salerno, Maria Oliviero, Ernesto Di Maio, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Polymorphisms of the CLCN7 gene are associated with BMD in womenUlrika Pettersson, Omar M E Albagha, Max Mirolo, et al.Arthritis Research & Therapy|August 15, 2021
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritisPaola Di Benedetto, Piero Ruscitti, Onorina Berardicurti, et al.Pageof 15